METTL3 and melanoma: Conditional ablation of METTL3 in CD4+CD8+ double-positive thymocytes disrupts m6A-dependent CREB1 translation and phosphorylation, impairing iNKT cell proliferation, lineage differentiation, and cytokine production, ultimately compromising antitumour immunity against melanoma.